3.03 The National Lung Matrix Trial&the Major Flaw of the SPRINT Trial with Dr. Mark Friedberg - a podcast by Vinay Prasad, MD MPH

This week we discuss two major papers: The first was just recently released in Nature and it's titled "The National Lung Matrix Trial of personalized therapy in lung cancer". The second is a few years old, but exemplifies the importance of trial design. We discuss the second paper, titled "A Randomized Trial of Intensive versus Standard Blood-Pressure Control" and published in the New England Journal of Medicine with Dr. Mark Friedberg, a health policies and performance measurement researcher.

National Lung Matrix Trial: doi.org/10.1038/s41586-020-2481-8SPRINT: doi.org/10.1056/NEJMoa1511939

Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Further episodes of Plenary Session

Further podcasts by Vinay Prasad, MD MPH

Website of Vinay Prasad, MD MPH